Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma

Canadian Journal of Urology

Volumn 18, Issue 1, 2011, Pages 5529-5536

  Arce, Jacobo ^a   Gaya, Josep M ^a   Huguet, Jorge ^a   Rodriguez, Oscar ^a   Palou, Joan ^a   Villavicencio, Humberto ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Carcinoma in situ; Cystectomy; Multifocality; Prostatic urethra neoplasm; Recurrence; Transitional cell carcinoma

Indexed keywords

ARTICLE; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; CARCINOMA IN SITU; CYSTECTOMY; HUMAN; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSTATE TUMOR; PROSTATECTOMY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 79959811679     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Herr HW, Donat SM. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome. J Urol 1999;161(6): 1854-1857.
2. Cheville JC, Dundore PA, Bostwick DG et al. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases. Cancer 1998;82(4):703-707.
3. Esrig D, Freeman JA, Elmajian DA, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996;156(3):1071-1076.
4. Njinou Ngninkeu B, Lorge F, Moulin P, Jamart J, Van Cangh PJ. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 2003; 169(1):149-152.
5. Schellhammer PF, Bean MA, Whitmore WF Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 1977;118(3):399-403.
6. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional call carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006; 37(6):726-734.
7. Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova JL, Almenar S. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J Urol 1995;154(5):1710-1713.
8. Vallancien G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G, Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 2002; 168(6):2413-2417.
9. Colombo R, Bertini R, Salonia A et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 2004; 171(5):1819-1822.
10. Bassi P. BCG (bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer. Surg Oncol 2002;11(1-2):77-83.
11. Davis JW, Sheth SI, Doviak MJ, Schellhammer PF. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year follow up. J Urol 2002;167(2 Pt 1):494-500.
12. Nixon RG, Chang SS, Lafleur BJ, Smith JA, Cookson MS. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 2002;167(2 Pt 1): 502-505.
13. Pettus JA, Al-Ahmadie H, Barocas DA et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008;53(2):370-375.
14. Weizer AZ, Shah RB, Lee CT et al. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy. Urol Oncol 2007;25(6):460-464.
15. Kefer JC, Volezke BB, Flanigan RC, Wojcik EM, Waters WB, Campbell SC. Risk assessment for occult malignancy in the prostate before radical cystectomy. Urology 2005;66(6):1251-1255.
16. Mungan MU, Canda AE, Tuzel E, Yorukoglu K, Kirkali Z. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder. Eur Urol 2005;48(5):760-763.
17. Solsona E, Iborra I, Ricós JV et al. Recurrence of superficial bladder tumors in prostatic urethra. Eur Urol 1991;19(2):89-92.
18. Wood DP Jr, Montie JE, Pontes JE, VanderBrug Medendorp S, Levin HS. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 1989;141(2):346-349.
19. Levinson AK, Johnson DE, Wishnow KI. Indications of urethrectomy in the era of continent urinary diversion. J Urol 1990; 144(1):73-75.
20. Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol 1990;144(3):666-669.
21. Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG. Urethral tumor recurrence following cystecomy and urinary diversion. Clinical and pathological characteristics in 768 male patients. J Urol 2005;173(4):1163-1168.
22. Freeman JA, Tarter TA, Esrig D et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 1996;156(5): 1615-1619.
23. Reese JH, Freiha FS, Gelb AB, Lum BL, Torti FM. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J Urol 1992;147(1):92-95.
24. Pagano F, Bassi P, Ferrante GL et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996; 155(1):244-247.
25. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004;171(2 Pt 1):646-651.
26. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163(1):73-78.
27. Huang GJ, Kim PH, Skinner DG, Stein JP. Outcomes of patients with clinical CIS-only disease treated with radical cystectomy. World J Urol 2009;27(1):21-25.
28. Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 2005;48(1):53-59.
29. Tobisu K, Tanaka Y, Mizutani T, Kakizoe T. Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors. J Urol 1991; 146(6):1551-1554. 30.Huguet J, Monllau V, Sabaté S et al. Diagnosis, risk factors and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol 2008;53(4):785-92.
30. Huguet J, Monllau V, Sabaté S et al. Diagnosis, risk factors and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients. Eur Urol